Safety and Efficacy of Low Molecular Weight Heparin Therapy During Pregnancy: Three Year Experience at a Tertiary Care Center

Author： Singh Nilanchali Varshney Priya Tripathi Reva Mala Y. Tyagi Shakun

Publisher： Springer Publishing Company

ISSN： 0971-9202

Source： The Journal of Obstetrics and Gynecology of India, Vol.63, Iss.6, 2013-12, pp. : 373-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The safety of low molecular weight heparin therapy during labor

By Maslovitz Sharon Many Ariel Landsberg Jessica Ascher Varon David Lessing Joseph Kupferminc Michael

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 17, Iss. 1, 2005-01 ,pp. : 39-43

Informa Healthcare

Access to resources Recommend Favorite

The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy

By Eldor A.

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 104, Iss. 1, 2002-08 ,pp. : 3-13

Elsevier

Access to resources Recommend Favorite

Osteopenic fractures in pregnancy: Is low molecular weight heparin (LMWH) implicated?

By Byrd L. M. Shiach C. R. Hay C. R. M. Johnston T. A.

Journal of Obstetrics & Gynaecology, Vol. 28, Iss. 5, 2008-07 ,pp. : 539-542

Informa Healthcare

Access to resources Recommend Favorite

Congenital antithrombin III deficiency in pregnancy treated with low-molecular-weight heparin

By O'Donovan Maura Byrne P.

Journal of Obstetrics & Gynaecology, Vol. 20, Iss. 1, 2000-01 ,pp. : 85-85

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome

By Fouda U. M. Sayed A. M. Ramadan D. I. Fouda I. M.

Journal of Obstetrics & Gynaecology, Vol. 30, Iss. 8, 2010-11 ,pp. : 842-846

Informa Healthcare

Access to resources Recommend Favorite